Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 01, 2021 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,726 | $14.64 | 96,595 | |
| Apr 01, 2021 | Director | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 3,621 | $23.15 | 92,974 | |
| Apr 01, 2021 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,726 | -- | -- | |
| Feb 03, 2021 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 527 | $19.24 | 59,746 | |
| Feb 01, 2021 | SVP and General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,000 | -- | 11,000 | |
| Feb 01, 2021 | SVP and General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 62,000 | -- | 62,000 | |
| Jan 20, 2021 | Director | Form 4 | Open market or private sale of non-derivative or derivative security | 6,500 | $18.53 | 77,911 | |
| Dec 18, 2020 | SVP Global Operations and R&D | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 733 | $14.29 | 22,615 | |
| Oct 31, 2020 | SVP/GM, VIT | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 849 | $10.62 | 45,004 | |
| Sep 14, 2020 | SVP/GM, VIT | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 45,853 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.